Literature DB >> 23813573

Evaluation of the staging systems for gastric cancer.

Chun-Wei Peng1, Lin-Wei Wang, Wei-Juan Zeng, Xiao-Jun Yang, Yan Li.   

Abstract

BACKGROUND: Some staging systems for gastric cancer (GC) have been developed as alternatives to the 6th and 7th TNM staging systems, including the Hybrid, tumor-ratio-metastasis (TRM), and Kiel staging systems. This study evaluated the overall performance of these systems for GC.
METHODS: A total of 540 GC patients undergoing surgical resection were staged using these five systems. Homogeneity, discrimination power, predictive accuracy, and complexity of these systems were compared.
RESULTS: Multivariate analyses showed that all of 7th pT, pN, and pM classifications were independent factors for GC prognosis (P < 0.001 for all). Compared with the other four systems, 7th TNM system had improved stage groups homogeneity (7 of 8 stage groups homogeneous), enhanced discrimination power (4 of 5, 5 of 7, 4 of 7, 3 of 7, and 1 of 4 adjacent stage groups were differentiated by the 6th, 7th TNM, Hybrid, TRM, and Kiel systems, respectively), and better prediction value for GC patients' outcome (AUC = 0.801, P < 0.001). In addition, the 7th TNM system did not increase the staging complexity (9 groups and 21 subgroups).
CONCLUSIONS: The 7th TNM staging system represents advancement in GC staging system for better prediction of clinical outcomes.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastric cancer; prognosis; staging system

Mesh:

Year:  2013        PMID: 23813573     DOI: 10.1002/jso.23360

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography.

Authors:  Francesco Giganti; Elena Orsenigo; Paolo Giorgio Arcidiacono; Roberto Nicoletti; Luca Albarello; Alessandro Ambrosi; Annalaura Salerno; Antonio Esposito; Maria Chiara Petrone; Damiano Chiari; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Gastric Cancer       Date:  2015-01-23       Impact factor: 7.370

2.  Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.

Authors:  Francesco Giganti; Alessandro Ambrosi; Maria C Petrone; Carla Canevari; Damiano Chiari; Annalaura Salerno; Paolo G Arcidiacono; Roberto Nicoletti; Luca Albarello; Elena Mazza; Francesca Gallivanone; Luigi Gianolli; Elena Orsenigo; Antonio Esposito; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Br J Radiol       Date:  2016-10-21       Impact factor: 3.039

3.  The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis.

Authors:  Jiu-Yang Liu; Chun-Wei Peng; Xiao-Jun Yang; Chao-Qun Huang; Yan Li
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  Association between neutrophil-lymphocyte ratio and lymph node metastasis in gastric cancer: A meta-analysis.

Authors:  Krishna Kotecha; Animesh Singla; Philip Townend; Neil Merrett
Journal:  Medicine (Baltimore)       Date:  2022-06-24       Impact factor: 1.817

5.  Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.

Authors:  Luigi Marano; Virginia Boccardi; Bartolomeo Braccio; Giuseppe Esposito; Michele Grassia; Marianna Petrillo; Modestino Pezzella; Raffaele Porfidia; Gianmarco Reda; Angela Romano; Michele Schettino; Angelo Cosenza; Giuseppe Izzo; Natale Di Martino
Journal:  World J Surg Oncol       Date:  2015-07-16       Impact factor: 2.754

6.  Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer.

Authors:  Jing Chen; Dongsheng Hong; You Zhai; Peng Shen
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

7.  Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis.

Authors:  Chun-Xiao Zhang; Shu-Yi Wang; Shuang-Qian Chen; Shuai-Long Yang; Lu Wan; Bin Xiong
Journal:  Onco Targets Ther       Date:  2016-06-27       Impact factor: 4.147

8.  Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity.

Authors:  Li Tang; Rui Duan; Yan-jun Zhong; Raymond A Firestone; Ya-ping Hong; Ji-guo Li; Yan-chao Xin; Han-lin Wu; Yan Li
Journal:  Mol Cancer       Date:  2014-03-03       Impact factor: 27.401

9.  Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases.

Authors:  Wei-Juan Zeng; Wen-Qin Hu; Lin-Wei Wang; Shu-Guang Yan; Jian-Ding Li; Hao-Liang Zhao; Chun-Wei Peng; Gui-Fang Yang; Yan Li
Journal:  Oncol Lett       Date:  2013-10-10       Impact factor: 2.967

10.  Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells.

Authors:  Chunwei Peng; Jiuyang Liu; Guifang Yang; Yan Li
Journal:  Int J Nanomedicine       Date:  2017-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.